Prostate cancer drug Zytiga gains US approval

May 5, 2011
Sales and Marketing Centocor Ortho Biotech, Johnson & Johnson, Zytiga, prostate cancer

Zytiga a new treatment for the most hard to treat cases of prostate cancer has been approved in the US. …

Sanofi-Aventis' Plavix (clopidogrel)

Plavix sales plummet in England

May 5, 2011
Sales and Marketing BMS, Plavix, Sanofi-Aventis, clopidogrel

GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …

Debiopharm and Yale University to develop autoimmune treatment

May 5, 2011
Research and Development Debiopharm, Yale University

Debiopharm is teaming up with researchers at Yale University to develop Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory …

Pfizer

Pfizer sales flat as Lipitor revenues decline

May 4, 2011
Sales and Marketing Pfizer

Pfizer’s sales decreased slightly in the first quarter after rising revenues in specialty care and emerging markets failed to offset …

Hospitals face greater than expected savings target

May 4, 2011
Monitor, NHS reforms, foundation trusts

Hospitals are being asked to nearly double their savings target as a result of the increasingly tough economic environment they …

Roche's Avastin (bevacizumab)

Avastin as effective as Lucentis in eye disease

May 4, 2011
Research and Development Lucentis, avastin, off label, wet AMD

Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …

Astellas adds senior executives to global development team

May 4, 2011
Research and Development appointment, research and development

Astellas Pharma has made four new senior appointments to its US-based global development team. Former Eli Lilly vice president of …

Service Insight: Due diligence in emerging markets for clinical development

May 4, 2011
Research and Development Service Insight, Talking Point, research and development

SERVICE INSIGHT Currently, the pharma industry is experiencing an unprecedented wave of blockbuster drug patent expiries. There is a lack …

Contract research news in brief

May 4, 2011
Research and Development contract research, cros, research and development

This week’s CRO news roundup includes Omnicare CR and LAB Research changing hands, Q1 financials for ICON and PPD and …

ABPI Code of Practice

UK pharma reassured over dealings with health bodies

May 3, 2011
Medical Communications, Sales and Marketing 2011 ABPI Code, Code of Practice, medical communications, risk-sharing

UK pharma has been reassured over the use of risk-sharing schemes with health bodies. The latest revisions to the ABPI …

US approval for Boehringer’s diabetes drug Tradjenta

May 3, 2011
Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Tradjenta, the once-daily oral type II diabetes treatment developed by Boehringer Ingelheim, has been approved by US regulators. The FDA …

Strides Arcolab facility gets the nod from FDA

May 3, 2011
Manufacturing and Production Pfizer, distribution issues

Indian pharmaceutical manufacturer Strides Arcolab has been given a green light from the FDA for a facility in Bangalore that’s …

Cephalon

Cephalon accepts Teva’s $6.8 billion white knight bid

May 3, 2011
Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics

Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …

Teva’s Irvine facility gets FDA green light

May 3, 2011
Manufacturing and Production FDA, Teva, manufacturing compliance

Teva Pharmaceutical Industries has said that an injectables facility in the USA, shut down last April after quality control problems, …

Watermeadow Medical expands

May 3, 2011
Medical Communications appointment, medical communications

Oxfordshire, UK-based medical communications consultancy Watermeadow Medical has welcomed 11 new members of staff to its UK roster.Chief among them …

Bosch boosts pharma processing ops with Oystar purchases

May 3, 2011
Manufacturing and Production Bosch, Hüttlin, Manesty, Oystar, pharma manufacturing

Bosch Packaging Technology is planning to expand its position in the pharmaceutical processing equipment sector with the purchase of two …

Mitsui gets bigger in Japan with contract manufacturing buy

April 28, 2011
Manufacturing and Production Mitsui, contract manufacturing

Japanese company Mitsui & Co has agreed to buy MBS Co, a company set up earlier this month to house …

Caliber opens ‘world’s largest plant production facility’

April 28, 2011
Manufacturing and Production Biopharmaceuticals, Caliber Biotherapeutics, G-Con LLC, biopharmaceutical manufacturing

A new facility dedicated to manufacturing biopharmaceuticals in plant cell culture – claimed to be the largest of its type …

Advertising for MSD's Innovace

Healthcare comms is changing fast – but hold onto this principle

April 28, 2011
Medical Communications advertising, communications, digital marketing, marketing

Having spent the last forty-plus years in and around the pharma industry, it’s an understatement to say I have seen …

GlaxoSmithKline

GSK sales suffer double-digit drop

April 28, 2011
Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline saw a hefty drop in revenue in the first three months of this year as it struggled to contend …

The Gateway to Local Adoption Series

Latest content